202 related articles for article (PubMed ID: 35087109)
1. Microfluidic device engineered to study the trafficking of multiple myeloma cancer cells through the sinusoidal niche of bone marrow.
Sui C; Zilberberg J; Lee W
Sci Rep; 2022 Jan; 12(1):1439. PubMed ID: 35087109
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma bone marrow niche.
Basak GW; Srivastava AS; Malhotra R; Carrier E
Curr Pharm Biotechnol; 2009 Apr; 10(3):345-6. PubMed ID: 19355944
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.
Ribatti D; Nico B; Vacca A
Int Rev Cell Mol Biol; 2015; 314():259-82. PubMed ID: 25619720
[TBL] [Abstract][Full Text] [Related]
4. Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.
Moschetta M; Kawano Y; Sacco A; Belotti A; Ribolla R; Chiarini M; Giustini V; Bertoli D; Sottini A; Valotti M; Ghidini C; Serana F; Malagola M; Imberti L; Russo D; Montanelli A; Rossi G; Reagan MR; Maiso P; Paiva B; Ghobrial IM; Roccaro AM
Curr Osteoporos Rep; 2017 Oct; 15(5):499-506. PubMed ID: 28889371
[TBL] [Abstract][Full Text] [Related]
5. A multi-niche microvascularized human bone marrow (hBM) on-a-chip elucidates key roles of the endosteal niche in hBM physiology.
Nelson MR; Ghoshal D; Mejías JC; Rubio DF; Keith E; Roy K
Biomaterials; 2021 Mar; 270():120683. PubMed ID: 33556648
[TBL] [Abstract][Full Text] [Related]
6. 3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.
de la Puente P; Muz B; Gilson RC; Azab F; Luderer M; King J; Achilefu S; Vij R; Azab AK
Biomaterials; 2015 Dec; 73():70-84. PubMed ID: 26402156
[TBL] [Abstract][Full Text] [Related]
7. Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma.
Abe M
Int J Hematol; 2011 Oct; 94(4):334-343. PubMed ID: 22005835
[TBL] [Abstract][Full Text] [Related]
8. Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment.
Belloni D; Heltai S; Ponzoni M; Villa A; Vergani B; Pecciarini L; Marcatti M; Girlanda S; Tonon G; Ciceri F; Caligaris-Cappio F; Ferrarini M; Ferrero E
Haematologica; 2018 Apr; 103(4):707-716. PubMed ID: 29326121
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma.
Wang J; Faict S; Maes K; De Bruyne E; Van Valckenborgh E; Schots R; Vanderkerken K; Menu E
Oncotarget; 2016 Jun; 7(25):38927-38945. PubMed ID: 26950273
[TBL] [Abstract][Full Text] [Related]
10. Endosteal and Perivascular Subniches in a 3D Bone Marrow Model for Multiple Myeloma.
Braham MVJ; Ahlfeld T; Akkineni AR; Minnema MC; Dhert WJA; Öner FC; Robin C; Lode A; Gelinsky M; Alblas J
Tissue Eng Part C Methods; 2018 May; 24(5):300-312. PubMed ID: 29652626
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma.
Riedel SS; Mottok A; Brede C; Bäuerlein CA; Jordán Garrote AL; Ritz M; Mattenheimer K; Rosenwald A; Einsele H; Bogen B; Beilhack A
PLoS One; 2012; 7(12):e52398. PubMed ID: 23300660
[TBL] [Abstract][Full Text] [Related]
12. A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing.
Tang X; Deng Z; Ding P; Qiang W; Lu Y; Gao S; Hu Y; Yang Y; Du J; Gu C
J Exp Clin Cancer Res; 2022 Mar; 41(1):85. PubMed ID: 35260179
[TBL] [Abstract][Full Text] [Related]
13. Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling.
Ho M; Chen T; Liu J; Dowling P; Hideshima T; Zhang L; Morelli E; Camci-Unal G; Wu X; Tai YT; Wen K; Samur M; Schlossman RL; Mazitschek R; Kavanagh EL; Lindsay S; Harada T; McCann A; Anderson KC; O'Gorman P; Bianchi G
Leukemia; 2020 Jan; 34(1):196-209. PubMed ID: 31142847
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow angiogenesis in multiple myeloma.
Vacca A; Ribatti D
Leukemia; 2006 Feb; 20(2):193-9. PubMed ID: 16357836
[TBL] [Abstract][Full Text] [Related]
15. The microenvironment and molecular biology of the multiple myeloma tumor.
Lemaire M; Deleu S; De Bruyne E; Van Valckenborgh E; Menu E; Vanderkerken K
Adv Cancer Res; 2011; 110():19-42. PubMed ID: 21704227
[TBL] [Abstract][Full Text] [Related]
16. Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.
Noll JE; Williams SA; Tong CM; Wang H; Quach JM; Purton LE; Pilkington K; To LB; Evdokiou A; Gronthos S; Zannettino AC
Haematologica; 2014 Jan; 99(1):163-71. PubMed ID: 23935020
[TBL] [Abstract][Full Text] [Related]
17. Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma.
Faid L; Van Riet I; De Waele M; Facon T; Schots R; Lacor P; Van Camp B
Eur J Haematol; 1996 Nov; 57(5):349-58. PubMed ID: 9003475
[TBL] [Abstract][Full Text] [Related]
18. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.
Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow adiposity and multiple myeloma.
Morris EV; Edwards CM
Bone; 2019 Jan; 118():42-46. PubMed ID: 29548987
[TBL] [Abstract][Full Text] [Related]
20. Piezo1-mediated mechanosensation in bone marrow macrophages promotes vascular niche regeneration after irradiation injury.
Zhang X; Hou L; Li F; Zhang W; Wu C; Xiang L; Li J; Zhou L; Wang X; Xiang Y; Xiao Y; Li SC; Chen L; Ran Q; Li Z
Theranostics; 2022; 12(4):1621-1638. PubMed ID: 35198061
[No Abstract] [Full Text] [Related]
[Next] [New Search]
